Several European Countries Resume Use of AstraZeneca Vaccine
France, Germany and Italy resumed use Friday of a coronavirus vaccine made by AstraZeneca after health officials sought to allay concerns it might cause blood clots.The European nations resumed inoculations after the European Medicines Agency (EMA) said the AstraZeneca-University of Oxford vaccine was “safe and effective” and the World Health Organization said “available data do not suggest any overall increase in clotting conditions” among those who had been vaccinated.From left, German public health expert Karl Lauterbach, RKI health institute deputy director Lars Schaade and German Health Minister Jens Spahn speak at a news conference, March 19, 2021, in Berlin, amid the COVID-19 pandemic.Germany and Italy are trying to avoid a third wave of coronavirus infections while France is experiencing its highest caseload in four months.Beginning Friday, several French regions, including…